Management of the Thyroid Nodule - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Management of the Thyroid Nodule

Description:

Management of the Thyroid Nodule Neil S Tolley MD FRCS DLO St Mary s Hospital 28th February 2002 Thyroid Nodule Malignant Disease rare, – PowerPoint PPT presentation

Number of Views:173
Avg rating:3.0/5.0
Slides: 13
Provided by: entformeds
Category:

less

Transcript and Presenter's Notes

Title: Management of the Thyroid Nodule


1
Management of the Thyroid Nodule
  • Neil S Tolley MD FRCS DLO
  • St Marys Hospital 28th February 2002

2
Thyroid Nodule
  • Malignant Disease rare, lt1 all malignancies.
    Only 15 mortality.
  • Benign Disease Common. 15 have a goitre. 7
    palpable. Over 8000 Thyroidectomies per annum in
    the uk.

3
Thyroid Nodule
  • Autopsy - 37 have nodules, 12 solitary
  • 5 have a clinically apparent solitary nodule
  • Overall incidence of malignancy is between 10-30
  • UK 3,000/annum 250 deaths
  • Deaths (anaplastic, medullary). Differentiated
    cancer death rate is relatively low

4
Thyroid Nodule
  • Clinician has to be surgically selective
  • Epidemiology
  • History
  • Examination
  • Investigations

5
Thyroid Nodule
  • Papillary 80, 80 multicentric. Seen in
    children. Nodes (60), 20 Lung metastases at
    presentation, Bone rare
  • Follicular 15 focal, older age (6th decade)
    Nodes (10), Lung Bone (20-30)
  • Medullary 4
  • Anaplastic 2
  • Others Hurthle, Lymphoma, Sarcoma, SCC,
  • Secondaries (breast, lung kidney)

6
Thyroid Nodule - Epidemiology
  • Papillary more common with DXT history
  • Incidence of Thyroid cancer 50 if received low
    dose DXT (800-1000 rads) TAs, Thymus, Skin
    problems
  • Belarus/Ukraine increased 12-34 fold
  • Follicular Iodine deficiency
  • Lymphoma Hashimotos

7
Thyroid Nodule History/Examination
  • Rapid growth, Fixed, Hard
  • Vocal cord palsy
  • Recurrent cystic nodule
  • Age very young or old
  • Neck node metastases
  • Sudden change in size of a thyroid nodule

8
Thyroid Nodule investigations
  • Haematological TFTs, Autoantibodies,
    Calcitonin, RET-proto-oncogene
  • Radiology USS, TC99m or Iodine131
  • FNAC
  • CT/MRI

9
Thyroid Nodule USS
  • 20 Solid, 5 Cystic - Malignant
  • Papillary Cloudy/Punctate (Psammoma bodies).
    Areas cystic necrosis common. Nodes may show
    calcification, can be solid or entirely cystic
    (chocolate cysts)
  • Follicular Rarely cystic. Amorphous
    calcification
  • Medullary Coarse or Psammomatous calcification.
    50 neck or mediastinal involvement. 33
    Familial
  • Hashimotos rarely necroses

10
Thyroid Nodule
  • Cold Nodules 20 malignant 5 hot
  • FNAC incidence of thyroid cancer in surgical
    specimens may reach 29
  • Sensitivity 86
  • Specificity 84
  • Negative predictive value 97

11
Thyroid Nodule
  • Risk assessment patient and tumour factors
  • Low risk papillary, age lt 45yrs,
    tumour lt 4cm
  • High risk Follicular, age gt 45 yrs, tumour gt
    4cm
  • Mortality 2 low, 45 high 15 intermediate

12
Thyroid Nodule
  • A nodule gt 3cm with Follicular cells has a 30
    chance of malignancy
  • Nodule 2-3cm observe, repeat USS and FNAC
  • Is this for the GPSI?
  • Education yes appropriate pre-assessment
    investigations can be requested, Bloods, USS
    FNAC.
  • Refer to ENT in the forum of a combined Thyroid
    clinic
  • The GPSI can be used to promote Thyroid surgery
    as a domain for the ENT surgeon
Write a Comment
User Comments (0)
About PowerShow.com